Hirsch Andrew
SEC insider (Form 3/4/5 filer). CIK 0001586707. Director at Editas Medicine, Inc. (EDIT) and 1 other issuer. 14 reported Form 4/5 transactions since Sep 2024; latest on Jun 17, 2026. Located in CAMBRIDGE, MA.
Companies Hirsch Andrew has filed insider reports for
- Editas Medicine, Inc. (EDIT): Director
- C4 Therapeutics, Inc. (CCCC): Director, Officer, President & CEO
Hirsch Andrew
CIK: 0001586707
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- Jun 17, 2026EDIT
Editas Medicine, Inc.
AwardDirectStock Option (right to buy)
51.7K shares- - Feb 15, 2026CCCC
C4 Therapeutics, Inc.
Tax PaymentDirect9.1K shares at avg. $1.89$17K - Feb 15, 2026CCCC
C4 Therapeutics, Inc.
ExerciseDirect20.4K shares- - Feb 14, 2026CCCC
C4 Therapeutics, Inc.
ExerciseDirect81.7K shares- - Feb 14, 2026CCCC
C4 Therapeutics, Inc.
Tax PaymentDirect39.2K shares at avg. $1.89$74K - Feb 13, 2026CCCC
C4 Therapeutics, Inc.
AwardDirect700K shares- - Jun 6, 2025EDIT
Editas Medicine, Inc.
AwardDirectStock Option (right to buy)
37.5K shares- - Feb 15, 2025CCCC
C4 Therapeutics, Inc.
Tax PaymentDirect9.4K shares at avg. $3.18$30K - Feb 14, 2025CCCC
C4 Therapeutics, Inc.
AwardDirect223.5K shares- - Feb 14, 2025CCCC
C4 Therapeutics, Inc.
Tax PaymentDirect12.8K shares at avg. $3.18$41K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 17, 2026 |  EDIT Editas Medicine, Inc. | Award Stock Option (right to buy) | 51,700 | - | - | Direct |
| Feb 15, 2026 |  CCCC C4 Therapeutics, Inc. | Tax Payment | 9,057 | $1.89 | $17,118 | Direct |
| Feb 15, 2026 | CCCC C4 Therapeutics, Inc. | Exercise | 20,400 | - | $0 | Direct |
| Feb 14, 2026 | CCCC C4 Therapeutics, Inc. | Exercise | 81,725 | - | $0 | Direct |
| Feb 14, 2026 | CCCC C4 Therapeutics, Inc. | Tax Payment | 39,154 | $1.89 | $74,001 | Direct |
| Feb 13, 2026 | CCCC C4 Therapeutics, Inc. | Award | 700,000 | - | $0 | Direct |
| Jun 6, 2025 | EDIT Editas Medicine, Inc. | Award Stock Option (right to buy) | 37,500 | - | - | Direct |
| Feb 15, 2025 | CCCC C4 Therapeutics, Inc. | Tax Payment | 9,370 | $3.18 | $29,797 | Direct |
| Feb 14, 2025 | CCCC C4 Therapeutics, Inc. | Award | 223,500 | - | - | Direct |
| Feb 14, 2025 | CCCC C4 Therapeutics, Inc. | Tax Payment | 12,847 | $3.18 | $40,853 | Direct |
1-10 of 14 transactions